Pulse Biosciences Appoints Burke T. Barrett As President and CEO, and Kevin Danahy As Chief Commercial Officer
Pulse Biosciences Appoints Burke T. Barrett As President and CEO, and Kevin Danahy As Chief Commercial Officer
05/14/24, 8:13 PM
Location
haywardIndustry
therapeutics
medical
biotechnology
health care
Position
chief commercial officer
Pulse Biosciences announced the appointment of Burke T. Barrett as President and Chief Executive Officer, while Kevin Danahy, former President and Chief Executive Officer, has been appointed as the Chief Commercial Officer to lead the pilot launch of the recently FDA cleared CellFX nsPFA Percutaneous Electrode System.
Company Info
Location
3957 point eden way
hayward, california, united states
Additional Info
Pulse Biosciences is the inventor and sole proprietor of Nanosecond Pulsed Field Ablation™ (nsPFA™) technology. We are committed to health innovation that has the potential to improve and extend the lives of patients. Our proprietary Nanosecond Pulsed Field Ablation technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue.